ALSTEM, INC
Biotechnology
Richmond, California, United States
14 employees
- Employees
- 14
- Contacts
- 3
- Emails
- 3
- Phones
- 2
ALSTEM, INC Overview
- Headquarters
- Richmond, California, United States
- Phone Number
- Available in AeroLeads
- Website
- alstembio.com
- Industry
- Biotechnology
- Employees
- 14
- Founded
- 2012
- Company Email
- Available in AeroLeads
About ALSTEM, INC
ALSTEM is an early stage biotech company based in the San Francisco Bay Area specializing in Induced pluripotent stem cells and reprogramming technologies. Founded in early 2012 by a team of scientists with deep experience in both academic and industrial biotechnology, ALSTEM is advancing frontiers in genome editing, virus packaging, cell immortalization, and iPS cell technology.
ALSTEM, INC Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 2
- 50.0% coverage
ALSTEM, INC Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Xinping Zhao | Chief Scientific Officer at Alstem, Llc | San Francisco Bay Area, United States |
Email
|
| Gang Li | Founder at Alstem | San Francisco Bay Area, United States |
Email
Phone
|
| Richard Tait | Life Sciences & Technology Marketing | San Mateo, California, United States |
Email
Phone
|
| Alstem Bio | Manager at Alstem | Albany, California, United States |
View
|
Employees by Management Level
Executive
2 profiles
Manager
2 profiles
Individual contributor
2 profiles
Director
1 profile
Associate / junior
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 1 | 1 | 0 |
Compare Similar Companies to ALSTEM, INC
Arsenal Biosciences, Inc.
Biotechnology Research
Neurona Therapeutics
Biotechnology Research
AllCells
Biotechnology Research
X-Therma Inc.
Biotechnology Research
ProMab Biotechnologies, Inc.
Biotechnology
Triplebar
Biotechnology Research
Alixia
Biotechnology Research
Equator Therapeutics
Biotechnology Research
Alsten
Multi-signal peer
Via Nova Therapeutics
Biotechnology